Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach

BACKGROUND: Diagnosis of dementia with Lewy bodies (DLB) is challenging, largely due to a lack of diagnostic tools. Cerebrospinal fluid (CSF) biomarkers have been proven useful in Alzheimer’s disease (AD) diagnosis. Here, we aimed to identify novel CSF biomarkers for DLB using a high-throughput prot...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Neurodegener
Asıl Yazarlar: van Steenoven, Inger, Koel-Simmelink, Marleen J. A., Vergouw, Leonie J. M., Tijms, Betty M., Piersma, Sander R., Pham, Thang V., Bridel, Claire, Ferri, Gian-Luca, Cocco, Cristina, Noli, Barbara, Worley, Paul F., Xiao, Mei-Fang, Xu, Desheng, Oeckl, Patrick, Otto, Markus, van der Flier, Wiesje M., de Jong, Frank Jan, Jimenez, Connie R., Lemstra, Afina W., Teunissen, Charlotte E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301448/
https://ncbi.nlm.nih.gov/pubmed/32552841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-020-00388-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller